Cardiol Therapeutics Inc. (FRA:CT9)
Germany · Delayed Price · Currency is EUR 0.8100
-0.0080 (-0.98%)
At close: Jan 26, 2026
Cardiol Therapeutics Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
18
Market Cap
88.12M EUR
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 78.76K | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Netfonds AG | 239.33M |
| Meta Wolf AG | 122.26M |
| InnoTec TSS AG | 117.90M |
| audius SE | 90.95M |
| CeoTronics AG | 68.83M |
| ParTec AG | 48.67M |
| Samara Asset Group | 3.40M |
| CGRE AG | 1.12M |